1. Kosinski M.A., Lipsky B.A.. Current medical management of diabetic foot infections.
Expert Rev Anti Infect Ther 8:2010;1293–1305.
2. Freeman A., May K., Frescos N., Wraight P.R.. Frequency of risk factors for foot ulceration in individuals with chronic kidney disease.
Intern Med J 38:2008;314–320.
3. Margolis D.J., Hofstad O., Feldmann H.I.. Association between renal failure and foot ulcer or lower-extremity amputation in patients with diabetes.
Diabetes Care 31:2008;1331–1336.
4. Van Houtum W.H., Lavery L.A., Harkless L.B.. The impact of diabetes-related lower-extremity amputations in the Netherlands.
J Diabetes Complications 10:1996;325–330.
5. Armstrong D.G., Wrobel J., JM Robbins. Guest editorial: are diabetes-related wounds and amputations worse than cancer?
Int Wound J 4:2007;286–287.
6. CJ Schofeld, Libby G., GM Brennan, RR MacAlpine, AD Morris, Leese G.P.. DARTS/MEMO collaboration: mortality and hospitalization in patients after amputation: a comparison between patients with and without diabetes.
Diabetes Care 29:2006;2252–2256.
7. Deery H.G. 2nd, Sangeorzan J.A.. Saving the diabetic foot with special reference to the patient with chronic renal failure.
Infect Dis Clin North Am 15:2001;953–981.
8. Morbach S., Quante C., Ochs H.R., Gaschler F., Pallast J.M., Knevels U.. Increased risk of lower extremity amputation among Caucasian diabetic patients on dialysis.
Diabetes Care 24:2001;1689–1690.
9. O’Hare A.M., Feinglass J., Reiber G.E., Rodriguez R.A., Daley J., Khuri S., Henderson W.G., Johansen K.L.. Postoperative mortality after nontraumatic lower extremity amputation in patients with renal insufficiency.
J Am Soc Nephrol 15:2004;427–434.
10. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.
Am J Kidney Dis 39:2002;1–266.
11. O'Rourke R.A., Brundage B.H., Froelicher V.F., Greenland P., Grundy S.M., Hachamovitch R., Pohost G.M., Shaw L.J., Weintraub W.S., Winters W.L. Jr. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease.
J Am Coll Cardiol 36:2000;326–340.
12. Shlipak M.G., Fried L.F., Cushman M., Manolio T.A., Peterson D., Stehman-Breen C., Bleyer A., Newman A., Siscovick D., Psaty B.. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors.
JAMA 293:2005;1737–1745.
13. Shlipak M.G., Heidenreich P.A., Noguchi H., Chertow G.M., Browner W.S., McClellan M.B.. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients.
Ann Intern Med 137:2002;555–562.
14. Beattie J.N., Soman S.S., Sandberg K.R., Yee J., Borzak S., Garg M., McCullough P.A.. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction.
Am J Kidney Dis 37:2001;1191–1200.
15. Raine A.E., Margreiter R., Brunner F.P., Ehrich J.H., Geerlings W., Landais P., Loirat C., Mallick N.P., Selwood N.H., Tufveson G.. Report on management of renal failure in Europe, XXII, 1991.
Nephrol Dial Transplant 7:1992;7–35.
16. deFilippi C., Wasserman S., Rosanio S., Tiblier E., Sperger H., Tocchi M., Christenson R., Uretsky B., Smiley M., Gold J., Muniz H., Badalamenti J., Herzog C., Henrich W.. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.
JAMA 290:2003;353–359.
17. Wanner C., Zimmermann J., Schwedler S., Metzger T.. Inflammation and cardiovascular risk in dialysis patients.
Kidney Int 61:2002;99–102.
18. Ridker P.M.. Clinical application of C-reactive protein for cardiovascular disease detection and prevention.
Circulation 107:2003;363–369.
19. Menon V., Greene T., Wang X., Pereira A.A., Marcovina S.M., Beck G.J., Kusek J.W., Collins A.J., Levey A.S., Sarnak M.J.. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease.
Kidney Int 68:2005;766–772.
20. Zimmermann J., Herrlinger S., Pruy A., Metzger T., Wanner C.. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.
Kidney Int 55:1999;648–658.
21. Reiber G.E., Vileikyte L., Boyko E.J., del Aguila M., Smith D.G., Lavery L.A., Boulton A.J.. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.
Diabetes Care 22:1999;157–162.
22. Pecoraro R.E., Reiber G.E., Burgess E.M.. Pathways to diabetic limb amputation. Basis for prevention.
Diabetes Care 13:1990;513–521.
23. American Diabetes Association. Peripheral arterial disease in people with diabetes.
Diabetes Care 26:2003;3333–3341.
24. Selby J.V., Zhang D.. Risk factors for lower extremity amputation in persons with diabetes.
Diabetes Care 18:1995;509–516.
25. Nather A., Bee C.S., Huak C.Y., Chew J.L., Lin C.B., Neo S., Sim E.Y.. Epidemiology of diabetic foot problems and predictive factors for limb loss.
J Diabetes Complications 22:2008;77–82.
26. Cho A.H., Lee S.B., Han S.J., Shon Y.M., Yang D.W., Kim B.S.. Impaired kidney function and cerebral microbleeds in patients with acute ischemic stroke.
Neurology 73:2009;1645–1648.
27. Ninomiya T., Kiyohara Y., Kubo M., Tanizaki Y., Doi Y., Okubo K., Wakugawa Y., Hata J., Oishi Y., Shikata K., Yonemoto K., Hirakata H., Iida M.. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study.
Kidney Int 68:2005;228–236.
28. Daly C.. Is early chronic kidney disease an important risk factor for cardiovascular disease? A background paper prepared for the UK Consensus Conference on early chronic kidney disease.
Nephrol Dial Transplant 22(Suppl 9):2007;ix19–25.
29. Takeda T., Hoshida S., Nishino M., Tanouchi J., Otsu K., Hori M.. Relationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive C-reactive protein levels.
Atherosclerosis 169:2003;155–158.
30. Stenvinkel P., Andersson P., Wang T., Lindholm B., Bergström J., Palmblad J., Heimbürger O., Cederholm T.. Do ACE-inhibitors suppress tumor necrosis factor-alpha production in advanced chronic renal failure?
J intern Med 246:1999;503–507.